Home General Biotechnology Drug Patent Expirations in April 2014

Drug Patent Expirations in April 2014

Drug Patent Expirations for April 2014

TradenameApplicantGeneric NamePatent NumberPatent Expiration
MAXALT-MLTMerckrizatriptan benzoate5,457,895*PEDApr 1, 2014
FROVAEndo Pharmsfrovatriptan succinate5,616,603Apr 1, 2014
ABELCETSigma Tauamphotericin b5,616,334Apr 1, 2014
BROVANASunovionarformoterol tartrate6,589,508Apr 3, 2014
INCRELEXIpsen Incmecasermin recombinant6,207,640Apr 7, 2014
VIRACEPTAgouronnelfinavir mesylate5,952,343*PEDApr 7, 2014
NIZORAL A-DMcneil Consketoconazole5,456,851Apr 7, 2014
VIRACEPTAgouronnelfinavir mesylate5,484,926*PEDApr 7, 2014
VIRACEPTAgouronnelfinavir mesylate6,162,812*PEDApr 7, 2014
INVEGA SUSTENNAJanssen Pharmspaliperidone palmitate5,254,556*PEDApr 15, 2014
ATELVIAWarner Chilcott Llcrisedronate sodium5,622,721Apr 21, 2014
ALREXBausch And Lombloteprednol etabonate5,540,930*PEDApr 25, 2014
LOTEMAXBausch And Lombloteprednol etabonate5,540,930*PEDApr 25, 2014
ZYLETBausch And Lombloteprednol etabonate; tobramycin5,540,930*PEDApr 25, 2014
ALREXBausch And Lombloteprednol etabonate5,747,061*PEDApr 25, 2014
LOTEMAXBausch And Lombloteprednol etabonate5,747,061*PEDApr 25, 2014
ZYLETBausch And Lombloteprednol etabonate; tobramycin5,747,061*PEDApr 25, 2014
ABREVAGlaxosmithklinedocosanol4,874,794Apr 28, 2014
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.